CV Sciences (CVSI) Profit After Tax (2011 - 2026)
CV Sciences' (CVSI) quarterly Profit After Tax came in at -$643000.0 in Q1 2026, down 489.91% year-on-year from $164910.6 in Q1 2025, and down 212.14% quarter-over-quarter from -$206000.0 in Q4 2025.
CV Sciences (CVSI) Profit After Tax (2011 - 2026) Analysis & Trends
CV Sciences has disclosed Profit After Tax across 16 years of filings, most recently posting -$643000.0 for Q1 2026.
- Profit After Tax for Q1 2026 came in at -$643000.0, down 489.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.5 million (up 20.43% YoY), and the FY2025 annual result was -$958000.0, up 59.98% from the prior year.
- Profit After Tax came in at -$643000.0 for Q1 2026 at CV Sciences, down from -$206000.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $5.7 million in Q1 2023 to a low of -$2.7 million in Q2 2022.
- The 5-year median for Profit After Tax is -$628000.0 (2024), against an average of -$535705.9.
- Across the five-year window, Profit After Tax tumbled 2477.5% in 2022 and surged 357.37% in 2023, its largest moves.
- CV Sciences' Profit After Tax stood at -$2.3 million in 2022, then soared by 62.43% to -$869000.0 in 2023, then rose by 16.46% to -$726000.0 in 2024, then surged by 71.63% to -$206000.0 in 2025, then slumped by 212.14% to -$643000.0 in 2026.
- The last three Profit After Tax figures came in at -$643000.0 (Q1 2026), -$206000.0 (Q4 2025), and -$382000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.36 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | -643,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -643,000.00 |
| Dec 31, 2025 | -206,000.00 |
| Sep 30, 2025 | -382,000.00 |
| Jun 30, 2025 | -261,000.00 |
| Mar 31, 2025 | -109,000.00 |
| Dec 31, 2024 | -726,000.00 |
| Sep 30, 2024 | -456,000.00 |
| Jun 30, 2024 | -584,000.00 |
| Mar 31, 2024 | -628,000.00 |
| Dec 31, 2023 | -869,000.00 |
| Sep 30, 2023 | -447,000.00 |
| Jun 30, 2023 | -1.29 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | -2.31 Mn |
| Sep 30, 2022 | -1.03 Mn |
| Jun 30, 2022 | -2.65 Mn |
| Mar 31, 2022 | -2.22 Mn |
| Dec 31, 2021 | -8.86 Mn |
| Sep 30, 2021 | -40,000.00 |
| Jun 30, 2021 | -3.53 Mn |